← ANALYST RATINGS · TIPRANKS
Lifecore Biomedical (LFCR): analyst forecast and price target
Analyst consensus
Hold0 Buy4 Hold0 Sell
Ratings of 4 analysts in the last 3 months · top analysts only12-month forecast
Based on 4 price targets given in the last 3 months, the average target is $6.28, the highest $6.28, the lowest $6.28. The average is −1.6% from the last price of $6.38.
| Analyst | Firm | Price target | Rating | Upside | Action | Date | Move vs SPY | |
|---|---|---|---|---|---|---|---|---|
| Jared Haase★★★★★★★★★★#1700 · hits 89% · avg +24.8% | William Blair | — | Hold | — | Downgrade | 03.10.26on TipRanks Oct 5 05:10 | −1.0%next day −1.6% · 5 days −1.6% | ↗ |
| AI xAi Drug Manufacturers - Specialty and GenericxAI Grok-3 | TipRanks - xAI | $4.00 → $6.50+62.5% | Hold | +1.9% | Reiterated | 30.09.26on TipRanks 03:05 | — | |
| AI DeepSeek Drug Manufacturers - Specialty and GenericDeepSeek R1-0528 | TipRanks - DeepSeek | $4.50 → $7.00+55.6% | Hold | +9.7% | Reiterated | 30.09.26on TipRanks 03:05 | — | |
| AI OpenAI Drug Manufacturers - Specialty and GenericOpenAI 4o | TipRanks - OpenAI | $4.00 → $6.50+62.5% | Hold | +1.9% | Reiterated | 30.09.26on TipRanks 03:05 | — | |
| AI Anthropic Drug Manufacturers - Specialty and GenericAnthropic Opus-4.1 | TipRanks - Anthropic | $4.00 → $7.00+75.0% | Hold | +9.7% | Reiterated | 30.09.26on TipRanks 03:05 | — | |
| AI Google Drug Manufacturers - Specialty and GenericGemini 2.5Pro | TipRanks - Google | $4.50 → $7.00+55.6% | Hold | +9.7% | Reiterated | 30.09.26on TipRanks 03:05 | — | |
| AI PerPlexity Drug Manufacturers - Specialty and GenericPerPlexity SonarPro | TipRanks - PerPlexity | $4.00 → $7.00+75.0% | Hold | +9.7% | Reiterated | 30.09.26on TipRanks 03:05 | — | |
| Michael Petusky★★★★★★★★★★#4246 · hits 45% · avg +2.3% | Barrington | — | Hold | — | Downgrade | 29.09.26on TipRanks 07:45 | +1.3%next day +0.1% · 5 days −4.1% | ↗ |
| Matt Hewitt★★★★★★★★★★#3011 · hits 47% · avg +4.1% | Craig-Hallum | $6.28 | Hold | −1.6% | Downgrade | 29.09.26on TipRanks Sep 28 14:05 | +56.0%next day +1.3% · 5 days −1.2% | ↗ |
| Jared Haase★★★★★★★★★★#1700 · hits 89% · avg +24.8% | William Blair | — | Hold | — | Downgrade | 29.09.26on TipRanks Sep 28 12:35 | +56.0%next day +1.3% · 5 days −1.2% | ↗ |
| Paul Knight★★★★★★★★★★#4215 · hits 45% · avg +3.5% | KeyBanc | — | Hold | — | Reiterated | 06.08.26on TipRanks 04:16 | +9.2%next day +2.9% · 5 days −3.5% | ↗ |
| Steven Etoch★★★★★★★★★★#2413 · hits 86% · avg +59.3% | Stephens | $8.50 → $5.00−41.2% | Hold | −21.6% | Reiterated | 17.03.26on TipRanks 10:00 | −0.4%next day −3.4% · 5 days −5.9% | ↗ |
| No ratings for this filter. | ||||||||
Every rating the collector has kept for the last 12 months, including the earlier ones of the same analyst. Latest of each analyst
How the average price target moved
The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 01.10.26: target $6.28 at a price of $6.58 (−4.6%); now: $6.28 at $6.38 (−1.6%).
PriceAverage targetTop analysts’ target
Recommendation trend · top analysts
Strong BuyBuyHoldSell
| Rating | 05.26 | 06.26 | 07.26 | 08.26 | 09.26 | 10.26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 1 | 1 | 0 | 0 | 0 |
| Buy | 7 | 6 | 6 | 7 | 5 | 4 |
| Hold | 1 | 0 | 0 | 1 | 3 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Best top-analyst consensus in the sector · Healthcare
About Lifecore Biomedical
- CEO: Paul Josephs
- Employees: 382
- 3515 Lyman Boulevard, Chaska, MN, 55318, US
- www.lifecore.com
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization that serves customers in the United States, Belgium, the Netherlands, and internationally. It provides services in the development, manufacture, aseptic fill, and finish of formulations and highly viscous sterile injectable pharmaceutical drug or medical device products in syringes, vials, and cartridges in various modalities. The company also manufactures and sells pharmaceutical-grade hyaluronic acid in bulk form, as well as for use in formulated and filled syringes and vials for injectable products used in treating various medical conditions and procedures, including ophthalmic and orthopedic applications. In addition, it offers product development services, including analytical method development and validation, formulation development, sterile filtration, process scale-up, pilot studies, stability studies, process validation, and materials production for clinical studies. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.
Data from the stock’s TipRanks forecast page, read 94 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗